Axonics® Announces Third Quarter 2018 Financial Results and Operational Update

Go back to Axonics® Announces Third Quarter 2018 Financial Results and Operational Update

Axonics Modulation Technologies Inc. (AXNX) Reports Q3 Loss of $2.67

December 11, 2018 4:01 PM EST

Axonics Modulation Technologies Inc. (NASDAQ: AXNX) reported Q3 EPS of ($2.67), versus ($0.43) reported last year. Revenue for the quarter came in at $200 thousand versus the consensus estimate of $100 thousand.

Raymond W. Cohen, CEO of Axonics commented, First and foremost, we are focused on concluding our ARTISAN-SNM pivotal clinical study where we... More